Human trials have begun on a groundbreaking anti-cancer drug, developed at UNSW, with the power to shrink tumours and potentially provide an alternative to chemotherapy.
With advances in nanotechnology, the future of medicine is taking shape on the nano-scale and making possible healthcare solutions once confined to the realm of science fiction.
Fears that involuntary exposure to chemicals in food and consumer products causes cancer are not supported by evidence, a leading Australian cancer researcher says.
Australian scientists have played a key role in the identification of a biochemical mechanism that allows brain cancers to survive and grow, offering hope of new treatments to combat some of the most aggressive tumours.
The medical research community can only be encouraged by the level of commitment demonstrated by the NSW government's $30 million funding to fast track cancer research, UNSW's Dean of Medicine, Professor Peter Smith, says.
Research into the attitudes of women toward genetic testing for cancer has received major backing in two separate rounds of state and federal government funding.
